Steven Cohen’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
Steven Cohen's JANX Position: Q3 2026 in Review
Steven Cohen reduced its Janux Therapeutics (JANX) stake by 21% in Q3 2026, selling an estimated $6.95M and leaving 1,579,984 shares worth $27.3M. The position accounts for 0.03% of the portfolio, ranked #733.
Steven Cohen first reported a position in JANX in Q2 2024 and has held it in 10 quarters since. The position peaked at $49.5M in Q2 2025. 202 funds tracked by Wall St. Rank hold JANX as of Q3 2026.
- Steven Cohen held 1,579,984 shares of Janux Therapeutics worth $27.3M as of Q3 2026.
- Steven Cohen sold 413,853 Janux Therapeutics shares in Q3 2026, an estimated $6.95M.
- Janux Therapeutics made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #733 holding.
- Steven Cohen first reported a position in Janux Therapeutics in Q2 2024 and has held it in 10 quarters since.
- Steven Cohen's Janux Therapeutics position peaked at $49.5M in Q2 2025.
- 202 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.